ALLMedicine™ Cardiogenic Shock Center

Nov 25th, 2022 - Transcatheter Treatment of Mitral Regurgitation in Cardiogenic Shock: Promises and Pitfalls.|2022|Lurz P,Besler C,|

Nov 25th, 2022 - Background Mechanical circulatory support devices, such as the intra-aortic balloon pump (IABP) and Impella, are often used in patients on veno-arterial extracorporeal life support (VA-ECLS) with cardiogenic shock despite limited supporting clinic...

Nov 25th, 2022 - Cardiogenic Shock: Searching for a Better Lifeboat.|2022|Baran DA,Brozzi N,|

Nov 23rd, 2022 - We present a case of a 30-year-old female with no pertinent medical history who presented with 4 days of chest pressure, dyspnea and fever. She had hemodynamic compromise and had elevated cardiac and inflammatory markers consistent with cardiogeni...

Nov 23rd, 2022 - Postcardiotomy cardiogenic shock (PCS) is associated with poor prognosis. Medical therapy with afterload reduction, contractility optimization and systemic vasopressors often fails, and mechanical support is required. The aim of this study was to ...

Oct 13th, 2022 - In the past years extensive efforts in developing treatment strategies for patients with cardiogenic shock have been performed. One promising such strategy is active unloading of the left ventricle while simultaneously supporting the circulatory s...

Oct 12th, 2022 - Scientific background - Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is used more and more frequently in patients with acute myocardial infarction (AMI) and refractory cardiogenic shock despite the absence of high level scientific ev...

Oct 12th, 2022 - Current management strategies for patients with SCAI stage C through E cardiogenic shock include management in a cardiac intensive care unit (CICU) or cardiac surgery intensive care unit (CSICU) with intravenous inotropes (i.e. medications to incr...

Oct 12th, 2022 - All consecutive patients with a confirmed cardiogenic shock presenting at the internal intensive care Unit (ICU) at the University of Mannheim are included in the register and followed up during ICU stay and after that. Data of patients' admission...

Oct 10th, 2022 - Primary end-point The primary endpoint (efficacy endpoint) is defined by a composite endpoint assessed at 1 month: All cause death; Need for ECMO; LVAD device implantation; Heart transplant In case of refractory cardiogenic shock (RCS), the use EC...

Nov 6th, 2022 - Routine early, expeditious use of extracorporeal membrane oxygenation (ECMO) is a common strategy in patients with severe cardiogenic shock, but a less aggressive initial approach may be just as effective, a randomized trial suggests. In the study...

Oct 17th, 2022 - The US Food and Drug Administration has granted 510(k) clearance for Abiomed's Impella Low Profile Sheath used to place and manage Impella heart pumps. "The Low Profile Sheath is the first sheath specifically engineered to be compatible with the I...

Oct 11th, 2022 - In patients undergoing coronary artery bypass graft (CABG) surgery for ischemic cardiomyopathy, adjunctive cardiac shockwave therapy (SWT) improved left ventricular ejection fraction (LVEF) in the single-center CAST-HF study. “We could show an imp...

Sep 23rd, 2022 - Bioprosthetic valve fracture (BVF) was associated with a doubling of in-hospital mortality in patients undergoing valve-in-valve transcatheter aortic valve replacement (ViV TAVR), new registry data show. The study also suggests that BVF performed ...

Sep 17th, 2022 - In patients with severe mitral regurgitation (MR) and cardiogenic shock, successful transcatheter edge-to-edge repair (TEER) is associated with a substantial reduction in all-cause mortality and lower morbidity at 1 year, according to an analysis ...